123 related articles for article (PubMed ID: 22900502)
1. Association between β2-adrenoceptor (ADRB2) haplotypes and insulin resistance in PCOS.
Tellechea ML; Muzzio DO; Iglesias Molli AE; Belli SH; Graffigna MN; Levalle OA; Frechtel GD; Cerrone GE
Clin Endocrinol (Oxf); 2013 Apr; 78(4):600-6. PubMed ID: 22900502
[TBL] [Abstract][Full Text] [Related]
2. The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study.
Hosseinpanah F; Barzin M; Tehrani FR; Azizi F
Clin Endocrinol (Oxf); 2011 Nov; 75(5):692-7. PubMed ID: 21592169
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of ADRB2 gene and their association with susceptibility for Plasmodium falciparum malaria and asthma in an Indian population.
Saadi AV; Gupta H; Angural A; Dhanya SK; Mony S; Oberoi D; D'Souza SC; Sahoo RC; Hande MH; Gopinath PM; Satyamoorthy K
Infect Genet Evol; 2013 Dec; 20():140-7. PubMed ID: 24012958
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome.
Koika V; Georgopoulos NA; Piouka A; Roupas ND; Karela A; Armeni AK; Katsantoni E; Panidis D
Eur J Endocrinol; 2012 Apr; 166(4):695-702. PubMed ID: 22223701
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of transcription factor-7-like 2 (TCF7L2) gene in Tunisian women with polycystic ovary syndrome (PCOS).
Ben-Salem A; Ajina M; Suissi M; Daher HS; Almawi WY; Mahjoub T
Gene; 2014 Jan; 533(2):554-7. PubMed ID: 24157263
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and haplotypes of insulin-like factor 3 gene are associated with risk of polycystic ovary syndrome in Indian women.
Shaikh N; Dadachanji R; Meherji P; Shah N; Mukherjee S
Gene; 2016 Feb; 577(2):180-6. PubMed ID: 26625974
[TBL] [Abstract][Full Text] [Related]
7. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
8. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria.
Shroff R; Syrop CH; Davis W; Van Voorhis BJ; Dokras A
Fertil Steril; 2007 Nov; 88(5):1389-95. PubMed ID: 17462641
[TBL] [Abstract][Full Text] [Related]
9. Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.
Pérez-Bravo F; Echiburú B; Maliqueo M; Santos JL; Sir-Petermann T
Clin Endocrinol (Oxf); 2005 Feb; 62(2):126-31. PubMed ID: 15670186
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.
Dravecká I; Lazúrová I; Habalová V
Gynecol Endocrinol; 2010 May; 26(5):356-60. PubMed ID: 20170352
[TBL] [Abstract][Full Text] [Related]
11. Genotypes and haplotypes of beta2-adrenergic receptor and parameters of the metabolic syndrome in Korean adolescents.
Park HS; Shin ES; Lee JE
Metabolism; 2008 Aug; 57(8):1064-70. PubMed ID: 18640383
[TBL] [Abstract][Full Text] [Related]
12. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
14. No association of the G972S polymorphism of the insulin receptor substrate-1 gene with polycystic ovary syndrome in lean PCOS women with biochemical hyperandrogenemia.
Marioli DJ; Koika V; Adonakis GL; Saltamavros AD; Karela A; Armeni AK; Tsapanos VS; Decavalas GO; Georgopoulos NA
Arch Gynecol Obstet; 2010 Jun; 281(6):1045-9. PubMed ID: 20012307
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS.
Celik O; Yesilada E; Hascalik S; Celik N; Sahin I; Keskin L; Ozerol E
Reprod Biomed Online; 2010 Apr; 20(4):492-8. PubMed ID: 20138007
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
DeUgarte CM; Bartolucci AA; Azziz R
Fertil Steril; 2005 May; 83(5):1454-60. PubMed ID: 15866584
[TBL] [Abstract][Full Text] [Related]
17. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of INS, INSR and IRS-1 genes are not associated with polycystic ovary syndrome in Croatian women.
Skrgatić L; Baldani DP; Gersak K; Cerne JZ; Ferk P; Corić M
Coll Antropol; 2013 Mar; 37(1):141-6. PubMed ID: 23697264
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
20. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
